查看购物车
  • Traditional Chinese
  • English
  • Japanese
影像诊断(DI)市场:市场规模，占有率，趋势，到分析:2033年为止的各产品类型，各地区，各市场区隔预测
市场调查报告书
商品编码
1359997

影像诊断(DI)市场:市场规模，占有率，趋势，到分析:2033年为止的各产品类型，各地区，各市场区隔预测

Diagnostic Imaging (DI) Market Size, Share, Trends and Analysis by Product Type, Region and Segment Forecast to 2033
出版日期: | 出版商: GlobalData | 英文 551 Pages | 订单完成后即时交付

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

诊断影像 (DI) 市场规模预计在 2023 年达到 365 亿美元，并预计在预测期内（2023-2033 年）复合年增长率为 4.2%。

凭藉最前沿的技术、以患者为中心的护理和预防性医疗保健，诊断成像市场的未来是光明的。预计该行业将继续在改善医疗保健结果和推动医学发展方面发挥重要作用。个人化医疗中的诊断影像有助于根据患者个别情况制定治疗计划，从而提高治疗效果并减少副作用。人工智慧和机器学习将成为诊断成像不可或缺的一部分，透过自动化影像分析和加速诊断来提高工作流程效率。

本报告提供全球影像诊断(DI)市场相关调查，并提供各产品类型，各市场区隔，各地区的趋势，今后的预测等资讯。

目录

目录

第1章 摘要整理

第2章 调查范围和市场区隔

第3章 影像诊断(DI)- 产业趋势分析

  • 影像诊断(DI)- 市场促进因素
  • 影像诊断(DI)- 市场阻碍因素
  • 影像诊断(DI)- 法规情形
  • 影像诊断(DI)- 偿付趋势

第4章 影像诊断(DI)的全球展望

  • 全球影像诊断(DI)市场- 收益概要(100万美元)
  • 全球影像诊断(DI):详细的市场规模预测(100万美元)
  • 全球影像诊断(DI)商机(100万美元)，各产品类型
  • 全球影像诊断(DI)市场- 各地区，2021年～2033年(100万美元)

第5章 影像诊断(DI)的各地区预测

  • 影像诊断(DI)- 各地区的概要与分析
  • 北美的影像诊断(DI)市场- 概要，2021年～2033年(100万美元)
  • 欧洲的诊断影像(DI)市场- 概要，2021年～2033年(100万美元)
  • 亚太地区的影像诊断(DI)市场- 概要，2021年～2033年(100万美元)
  • 中南美的影像诊断(DI)市场- 概要，2021年～2033年(100万美元)
  • 中东·非洲的影像诊断(DI)市场- 概要，2021年～2033年(100万美元)

第6章 竞争情形

  • 影像诊断:竞争情形概要
  • 影像诊断:企业占有率分析

第7章 企业简介

  • Bayer AG
  • Beijing Pharmaceutical Group Co Ltd
  • Bracco SpA
  • Canon Inc
  • Cardinal Health Inc
  • Diagnostic Medical Systems SA
  • Fujifilm Holdings Corp
  • DuPont de Nemours Inc
  • Guerbet SA
  • GE Healthcare
  • Hitachi Ltd
  • Hologic Inc
  • Nemoto Kyorindo Co Ltd
  • Koninklijke Philips NV
  • Neusoft Corp.
  • Novartis AG
  • Shimadzu Corp
  • Siemens AG
  • Swissray Global Healthcare Holding Ltd
  • Ulrich GmbH & Co KG
  • Ziehm Imaging Gmbh

第10章 调查手法

第11章 关于GlobalData

Product Code: GRCBBR00003ME

Abstract

The Diagnostic Imaging (DI) market will be valued at $36.5 billion in 2023 and is expected to grow at a CAGR of 4.2% over the forecast period (2023-2033). The DI report provides an executive-level overview of the DI industry worldwide today, with detailed forecasts of key indicators up to 2033.

This market intelligence report offers a thorough, forward-looking analysis of the global Diagnostic Imaging (DI) market by product type, regional segments, and key opportunities in a concise format to help executives build proactive and profitable growth strategies.

The global Diagnostic Imaging (DI) market will be valued at $36.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% over the forecast period. The diagnostic imaging market's future is bright, with technology, patient-centric care, and preventive healthcare at the forefront. This industry will continue to play a crucial role in improving healthcare outcomes and advancing medical science. Diagnostic imaging in personalized medicine, helps in tailor treatment plans to individual patient profiles, thereby improving treatment efficacy and reducing adverse effects. AI and machine learning will become integral to diagnostic imaging, automating image analysis and expediting diagnosis, thereby improving workflow efficiency.

Scope

  • This report provides overview and service addressable market for global Diagnostic Imaging (DI) market
  • It identifies the key drivers and restraints impacting growth of the DI market over the next 12 to 24 months.
  • It includes global market forecasts for the DI market and reimbursement scenario, and regulatory trends.
  • It covers detailed segmentation by product type - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectorst, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents, along with regional segmentation.

Reasons to Buy

  • This market intelligence report offers a thorough, forward-looking analysis of the global Diagnostic Imaging (DI) market by product type, regional segments in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData's Forecast products, the report examines the drivers, challenges, and regulatory trend analysis in the DI market.
  • Detailed segmentation by product type - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems, Contrast Media Injectorst, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems, X-ray Systems, Contrast Agents, and Nuclear Imaging Agents, along with vertical and regional segmentation.
  • The report includes 100+ charts and tables providing in-depth analysis of the market size, forecast, and supporting factors which are tailor-made for an executive-level audience, with enhanced presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from local market players, which enables executives to quickly get up to speed with the current and emerging trends in DI markets.
  • The competitive section of the report helps in identifying the flagbearers, experimenters, contenders, and specialists based on their growth and innovation performance in the DI industry which will help stakeholders analyze competition penetration.
  • The broad perspective of the report, coupled with comprehensive, actionable detail, will help DI vendors and other companies succeed in the growing DI market globally.

Table of Contents

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Research Scope and Segmentation

  • 2.1 Diagnostic Imaging (DI): Market Segmentation and Scope
  • 2.2 Diagnostic Imaging (DI): Market Definitions

Chapter 3 Diagnostic Imaging (DI) - Industry Trend Analysis

  • 3.1 Diagnostic Imaging (DI) - Market Drivers
  • 3.2 Diagnostic Imaging (DI) - Market Restraints
  • 3.3 Diagnostic Imaging (DI) - Regulatory Landscape
  • 3.4 Diagnostic Imaging (DI) - Reimbursement Trends

Chapter 4 Diagnostic Imaging (DI) Global Outlook

  • 4.1 Global Diagnostic Imaging (DI) Market - Revenue Snapshot ($M)
  • 4.2 Global Diagnostic Imaging (DI): Detailed Market Size Estimates($M)
  • 4.3 Global Diagnostic Imaging (DI) Revenue Opportunity by Product Type($M)
  • 4.4 Global Diagnostic Imaging (DI) Market - By Region, 2021-2033 ($M)

Chapter 5 Diagnostic Imaging (DI) Regional Outlook

  • 5.1 Diagnostic Imaging (DI) - Regional Overview & Analysis
  • 5.2 North America Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.2.1 North America Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.2.2 US Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.2.2.1 US Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.2.3 Canada Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.2.3.1 Canada Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.2.4 Mexico Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.2.4.1 Mexico Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
  • 5.3 Europe Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.1 Europe Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.3.2 France Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.2.1 France Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.3.3 Germany Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.3.1 Germany Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.3.4 Italy Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.4.1 Italy Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.3.5 Spain Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.5.1 Spain Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.3.6 The Netherlands Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.6.1 The Netherlands Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.3.7 Switzerland Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.7.1 Switzerland Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.3.8 UK Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.8.1 UK Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.3.9 Rest of Europe Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.3.9.1 Rest of Europe Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
  • 5.4 Asia Pacific Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.4.1 Asia Pacific Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.4.2 China Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.4.2.1 China Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.4.3 India Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.4.3.1 India Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.4.4 Japan Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.4.4.1 Japan Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.4.5 Australia Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.4.5.1 Australia Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.4.6 Rest of Asia-Pacific Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.4.6.1 Rest of Asia-Pacific Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
  • 5.5 South & Central America Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.5.1 South & Central America Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.5.2 Argentina Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.5.2.1 Argentina Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.5.3 Brazil Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.5.3.1 Brazil Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.5.4 Chile Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.5.4.1 Chile Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
  • 5.6 Middle East & Africa Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.6.1 Middle East & Africa Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.6.2 United Arab Emirates Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.6.2.1 United Arab Emirates Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.6.3 Saudi Arabia Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.6.3.1 Saudi Arabia Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.6.4 South Africa Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.6.4.1 South Africa Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)
    • 5.6.5 Rest of Middle East & Africa Diagnostic Imaging (DI) Market - Overview, 2021-2033 ($M)
    • 5.6.5.1 Rest of Middle East & Africa Diagnostic Imaging (DI) Revenue Opportunity by Product Type, 2021-2033 ($M)

Chapter 6 Competitive Landscape

  • 6.1 Diagnostic Imaging: Competitive Landscape Overview
  • 6.2 Diagnostic Imaging: Company Share Analysis

Chapter 7 Company Profiles

  • 7.1 Bayer AG: Overview
    • 7.1.1 Bayer AG: DI Offerings
    • 7.1.2 Bayer AG: Financials
    • 7.1.3 Bayer AG: SWOT Analysis
    • 7.1.4 Bayer AG: Key Personnel
  • 7.2 Beijing Pharmaceutical Group Co Ltd: Overview
    • 7.2.1 Beijing Pharmaceutical Group Co Ltd: DI Offerings
    • 7.2.2 Beijing Pharmaceutical Group Co Ltd: Key Personnel
  • 7.3 Bracco SpA: Overview
    • 7.3.1 Bracco SpA: DI Offerings
    • 7.3.2 Bracco SpA: SWOT Analysis
    • 7.3.3 Bracco SpA: Key Personnel
  • 7.4 Canon Inc: Overview
    • 7.4.1 Canon Inc: DI Offerings
    • 7.4.2 Canon Inc: Financials
    • 7.4.3 Canon Inc: SWOT Analysis
    • 7.4.4 Canon Inc: Key Personnel
  • 7.5 Cardinal Health Inc: Overview
    • 7.5.1 Cardinal Health Inc: DI Offerings
    • 7.5.2 Cardinal Health Inc: Financials
    • 7.5.3 Cardinal Health Inc: SWOT Analysis
    • 7.5.4 Cardinal Health Inc: Key Personnel
  • 7.6 Diagnostic Medical Systems SA: Overview
    • 7.6.1 Diagnostic Medical Systems SA: DI Offerings
    • 7.6.2 Diagnostic Medical Systems SA: Financials
    • 7.6.3 Diagnostic Medical Systems SA: Key Personnel
  • 7.7 Fujifilm Holdings Corp: Overview
    • 7.7.1 Fujifilm Holdings Corp: DI Offerings
    • 7.7.2 Fujifilm Holdings Corp: Financials
    • 7.7.3 Fujifilm Holdings Corp: SWOT Analysis
    • 7.7.2 Fujifilm Holdings Corp: Key Personnel
  • 7.8 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): Overview
    • 7.8.1 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): DI Offerings
    • 7.8.2 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): Financials
    • 7.8.3 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): SWOT Analysis
    • 7.8.4 DuPont de Nemours Inc (Key Subsidiary of Corteva Inc): Key Personnel
  • 7.9 Guerbet SA: Overview
    • 7.9.1 Guerbet SA: DI Offerings
    • 7.9.2 Guerbet SA: Financials
    • 7.9.3 Guerbet SA: SWOT Analysis
    • 7.9.4 Guerbet SA: Key Personnel
  • 7.10 GE Healthcare: Overview
    • 7.10.1 GE Healthcare: DI Offerings
    • 7.10.2 GE Healthcare: Financials
    • 7.10.3 GE Healthcare: SWOT Analysis
    • 7.10.4 GE Healthcare: Key Personnel
  • 7.11 Hitachi Ltd: Overview
    • 7.11.1 Hitachi Ltd: DI Offerings
    • 7.11.2 Hitachi Ltd: Financials
    • 7.11.3 Hitachi Ltd: SWOT Analysis
    • 7.11.4 Hitachi Ltd: Key Personnel
  • 7.12 Hologic Inc: Overview
    • 7.12.1 Hologic Inc: DI Offerings
    • 7.12.2 Hologic Inc: Financials
    • 7.12.3 Hologic Inc: SWOT Analysis
    • 7.12.4 Hologic Inc: Key Personnel
  • 7.13 Nemoto Kyorindo Co Ltd: Overview
    • 7.13.1 Nemoto Kyorindo Co Ltd: DI Offerings
    • 7.13.2 Nemoto Kyorindo Co Ltd: Key Personnel
  • 7.14 Koninklijke Philips NV: Overview
    • 7.14.1 Koninklijke Philips NV: DI Offerings
    • 7.14.2 Koninklijke Philips NV: Financials
    • 7.14.3 Koninklijke Philips NV: SWOT Analysis
    • 7.14.4 Koninklijke Philips NV: Key Personnel
  • 7.15 Neusoft Corp.: Overview
    • 7.15.1 Neusoft Corp: DI Offerings
    • 7.15.2 Neusoft Corp: Financials
    • 7.15.3 Neusoft Corp: SWOT Analysis
    • 7.15.4 Neusoft Corp: Key Personnel
  • 7.16 Novartis AG: Overview
    • 7.16.1 Novartis AG: DI Offerings
    • 7.16.2 Novartis AG: Financials
    • 7.16.3 Novartis AG: SWOT Analysis
    • 7.16.4 Novartis AG: Key Personnel
  • 7.17 Shimadzu Corp: Overview
    • 7.17.1 Shimadzu Corp: DI Offerings
    • 7.17.2 Shimadzu Corp: Financials
    • 7.17.3 Shimadzu Corp: SWOT Analysis
    • 7.17.4 Shimadzu Corp: Key Personnel
  • 7.18 Siemens AG: Overview
    • 7.18.1 Siemens AG: DI Offerings
    • 7.18.2 Siemens AG: Financials
    • 7.18.3 Siemens AG: SWOT Analysis
    • 7.18.4 Siemens AG: Key Personnel
  • 7.19 Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd).: Overview
    • 7.19.1 Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd): Financials
  • 7.20 Ulrich GmbH & Co KG: Overview
    • 7.20.1 Ulrich GmbH & Co KG: DI Offerings
    • 7.20.2 Ulrich GmbH & Co KG: Key Personnel
  • 7.21 Ziehm Imaging Gmbh: Overview
    • 7.21.1 Ziehm Imaging Gmbh: DI Offerings
    • 7.21.2 Ziehm Imaging Gmbh: Key Personnel

Chapter 10 Research Methodology

Chapter 11 About GlobalData

List of Tables

List of Tables

  • Table 1: Table: Diagnostic Imaging - Regulatory landscape (Top 5 countries)
  • Table 2: Diagnostic Imaging - Reimbursement Scenario (Top 5 countries)
  • Table 3: Diagnostic Imaging Market Revenue, by Product Type ($M), 2021-2033
  • Table 4: Global DI Market by Region ($M), 2021-2033
  • Table 5: Bayer AG Diagnostic Imaging Offerings
  • Table 6: Bayer AG Key Personnel
  • Table 7: Beijing Pharmaceutical Group Co Ltd Diagnostic Imaging Offerings
  • Table 8: Beijing Pharmaceutical Group Co Ltd Key Personnel
  • Table 9: Bracco SpA Imaging Offerings
  • Table 10: Bracco SpA Key Personnel
  • Table 11: Canon Inc Diagnostic Imaging Offerings
  • Table 12: Canon Inc Key Personnel
  • Table 13: Cardinal Health Inc Diagnostic Imaging Offerings
  • Table 14: Cardinal Health Inc Key Personnel
  • Table 15: Diagnostic Medical Systems SA Diagnostic Imaging Offerings
  • Table 16: Diagnostic Medical Systems SA Key Personnel
  • Table 17: DuPont de Nemours Inc (Key Subsidiary of Corteva Inc) Diagnostic Imaging Offerings
  • Table 18: DuPont de Nemours Inc (Key Subsidiary of Corteva Inc) Key Personnel
  • Table 19: Fujifilm Holdings Corp Diagnostic Imaging Offerings
  • Table 20: Fujifilm Holdings Corp Key Personnel
  • Table 21: GE Healthcare Diagnostic Imaging Offerings
  • Table 22: GE Healthcare Key Personnel
  • Table 23: Guerbet SA Diagnostic Imaging Offerings
  • Table 24: Guerbet SA Key Personnel
  • Table 25: Hitachi Ltd Diagnostic Imaging Offerings
  • Table 26: Hitachi Ltd Key Personnel
  • Table 27: Hologic Inc Diagnostic Imaging Offerings
  • Table 28: Hologic Inc Key Personnel
  • Table 29: Koninklijke Philips NV Diagnostic Imaging Offerings
  • Table 30: Koninklijke Philips NV Key Personnel
  • Table 31: Nemoto Kyorindo Co Ltd Diagnostic Imaging Offerings
  • Table 32: Nemoto Kyorindo Co Ltd Key Personnel
  • Table 33: Neusoft Corp Diagnostic Imaging Offerings
  • Table 34: Neusoft Corp Key Personnel
  • Table 35: Novartis AG Diagnostic Imaging Offerings
  • Table 36: Novartis AG Key Personnel
  • Table 37: Shimadzu Corp Diagnostic Imaging Offerings
  • Table 38: Shimadzu Corp Key Personnel
  • Table 39: Siemens AG Diagnostic Imaging Offerings
  • Table 40: Siemens AG Key Personnel
  • Table 41: Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd) Diagnostic Imaging Offerings
  • Table 42: Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd) Key Personnel
  • Table 43: Ulrich GmbH & Co KG Diagnostic Imaging Offerings
  • Table 44: Ulrich GmbH & Co KG Key Personnel
  • Table 45: Ziehm Imaging Gmbh Diagnostic Imaging Offerings
  • Table 46: Ziehm Imaging Gmbh Key Personnel
  • Table 47: Perry Baromedical Diagnostic Imaging Offerings
  • Table 48: Haux-Life-Support Diagnostic Imaging Offerings

List of Figures

List of Figures

  • Figure 1: Key Diagnostic Imaging (DI) Country Markets ($B), 2022 vs 2033
  • Figure 2: Diagnostic Imaging (DI) Market by Region, 2022 ($M)
  • Figure 3: Global Diagnostic Imaging Market Size & Forecasts ($M), 2021-2033
  • Figure 4: Global Diagnostic Imaging Market Size & Forecasts by Product Type ($M), 2021-2033
  • Figure 5: Global DI Market Estimates ($M) & CAGR (%), By Region (2023 vs 2033)
  • Figure 6: DI Regional Overview ($M), 2023 & 2033
  • Figure 7: North America Diagnostic Imaging Market ($M), 2021-2033
  • Figure 8: North America DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 9: US DI Market ($M), 2021-2033
  • Figure 10: US DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 11: Canada DI Market ($M), 2021-2033
  • Figure 12: Canada DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 13: Mexico DI Market ($M), 2021-2033
  • Figure 14: Mexico DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 15: Europe Diagnostic Imaging Market ($M), 2021-2033
  • Figure 16: Europe DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 17: France DI Market ($M), 2021-2033
  • Figure 18: France DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 19: Germany DI Market ($M), 2021-2033
  • Figure 20: Germany DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 21: Italy DI Market ($M), 2021-2033
  • Figure 22: Italy DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 23: Spain DI Market ($M), 2021-2033
  • Figure 24: Spain DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 25: United Kingdom DI Market ($M), 2021-2033
  • Figure 26: United Kingdom DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 27: Switzerland DI Market ($M), 2021-2033
  • Figure 28: Switzerland DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 29: The Netherlands DI Market ($M), 2021-2033
  • Figure 30: The Netherlands DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 31: Rest of Europe DI Market ($M), 2021-2033
  • Figure 32: Rest of Europe DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 33: Asia-Pacific Diagnostic Imaging Market ($M), 2021-2033
  • Figure 34: Asia-Pacific DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 35: China DI Market ($M), 2021-2033
  • Figure 36: China DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 37: India DI Market ($M), 2021-2033
  • Figure 38: India DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 39: Japan DI Market ($M), 2021-2033
  • Figure 40: Japan DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 41: Australia DI Market ($M), 2021-2033
  • Figure 42: Australia DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 43: Rest of Asia-Pacific DI Market ($M), 2021-2033
  • Figure 44: Rest of Asia-Pacific DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 45: South and Central America Diagnostic Imaging Market ($M), 2021-2033
  • Figure 46: South and Central America DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 47: Argentina DI Market ($M), 2021-2033
  • Figure 48: Argentina DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 49: Brazil DI Market ($M), 2021-2033
  • Figure 50: Brazil DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 51: Chile DI Market ($M), 2021-2033
  • Figure 52: Chile DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 53: Middle East and Africa Diagnostic Imaging Market ($M), 2021-2033
  • Figure 54: Middle East and Africa DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 55: United Arab Emirates DI Market ($M), 2021-2033
  • Figure 56: United Arab Emirates DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 57: Saudi Arabia DI Market ($M), 2021-2033
  • Figure 58: Saudi Arabia DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 59: South Africa DI Market ($M), 2021-2033
  • Figure 60: South Africa DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 61: Rest of MEA DI Market ($M), 2021-2033
  • Figure 62: Rest of MEA DI Market Size & Forecasts by Product Type($M), 2021-2033
  • Figure 63: Ultrasound Systems Key Players Market Share in 2022
  • Figure 64: Computed Tomography (CT) Systems Key Players Market Share in 2022
  • Figure 65: MRI Systems Key Players Market Share in 2022
  • Figure 66: Contrast Agents Key Players Market Share in 2022
  • Figure 67: X-ray Systems Key Players Market Share in 2022
  • Figure 68: Nuclear Imaging Equipment Key Players Market Share in 2022
  • Figure 69: Angio Suites Key Players Market Share in 2022
  • Figure 70: Mammography Equipment Key Players Market Share in 2022
  • Figure 71: C-Arms Key Players Market Share in 2022
  • Figure 72: Contrast Media Injectors Key Players Market Share in 2022
  • Figure 73: Nuclear Imaging Agents Key Players Market Share in 2022
  • Figure 74: Bone Densitometers Key Players Market Share in 2022
  • Figure 75: Bayer AG Financial Performance (EUR Million)
  • Figure 76: Canon Inc Financial Performance (JPY Million)
  • Figure 77: Cardinal Health Inc (USD Million)
  • Figure 78: Diagnostic Medical Systems SA Financial Performance (EUR Million)
  • Figure 79: DuPont de Nemours Inc (Key Subsidiary of Corteva Inc) Financial Performance (USD Million)
  • Figure 80: Fujifilm Holdings Corp Financial Performance (JPY Million)
  • Figure 81: GE Healthcare Financial Performance (USD Million)
  • Figure 82: Guerbet SA Financial Performance (EUR Million)
  • Figure 83: Hitachi Ltd Financial Performance (JPY Million)
  • Figure 84: Hologic Inc Financial Performance (USD Million)
  • Figure 85: Koninklijke Philips NV Financial Performance (EUR Million)
  • Figure 86: Neusoft Corp Financial Performance (CNY Million)
  • Figure 87: Novartis AG Financial Performance (USD Million)
  • Figure 88: Shimadzu Corp Financial Performance (JPY Million)
  • Figure 89: Siemens AG Financial Performance (EUR Million)
  • Figure 90: Swissray Global Healthcare Holding Ltd (S and S Healthcare Holding Ltd) Financial Performance (TWD Million)
  • Figure 91: Research Methodology Steps
  • Figure 92: Core Objectives of the Market Study
  • Figure 93: Research Approach
  • Figure 94: Analysis Flow
  • Figure 95: Quality Control Flow